Defective proviruses rapidly accumulate during acute HIV-1 infection

Cited by (745)

Items 201–300 of 745

1. γδ T cells: an immunotherapeutic approach for HIV cure strategies
   Carolina Garrido, Matthew L. Clohosey, Chloe P. Whitworth, Michael G. Hudgens, David M. Margolis, Natalia Soriano-Sarabia · 2018 · JCI Insight
2. HIV latency reversing agents act through Tat post translational modifications
   Georges Khoury, Talia M. Mota, Shuang Li · 2018 · Retrovirology
3. CRISPR/Cas9 Genome Editing to Disable the Latent HIV-1 Provirus
   Amanda R. Panfil, James A. London, Patrick L. Green, Kristine E. Yoder · 2018 · Frontiers in Microbiology
4. The inhibitor apoptosis protein antagonist Debio 1143 Is an attractive HIV-1 latency reversal candidate
   Michael D. Bobardt, Joseph Kuo, Udayan Chatterji, Sumit K. Chanda, Susan J. Little, Norbert Wiedemann, Grégoire Vuagniaux, Philippe A. Gallay · 2019 · PLoS ONE
5. Intact HIV Proviruses Persist in Children Seven to Nine Years after Initiation of Antiretroviral Therapy in the First Year of Life
   Mary Grace Katusiime, Elias Konstantine Halvas, Imogen A. Wright et al. · 2019 · Journal of Virology
6. Reduced Frequency of Cells Latently Infected With Replication-Competent Human Immunodeficiency Virus-1 in Virally Suppressed Individuals Living in Rakai, Uganda
   Jessica L. Prodger, Jun Lai, Steven James Reynolds, Jeanne C. Keruly, Richard D. Moore, Jingo Kasule, Taddeo Kityamuweesi, Paul Buule, David Serwadda, Martha Nason et al. · 2017 · Clinical Infectious Diseases
7. Rapid decline of HIV-1 DNA and RNA in infants starting very early antiretroviral therapy may pose a diagnostic challenge
   Kirsten A. Veldsman, Jean Maritz, Shahieda Isaacs · 2018 · AIDS
8. Inducible HIV RNA transcription assays to measure HIV persistence: pros and cons of a compromise
   Johann Plantin, Marta Massanella, Nicolas Chomont · 2018 · Retrovirology
9. Chromatin maturation of the HIV-1 provirus in primary resting CD4+ T cells
   Birgitta Lindqvist, Sara Svensson Akusjärvi, Anders B. Sönnerborg, Marios Dimitriou, J. Peter Svensson · 2020 · PLoS Pathogens
10. The Role of Tissue Resident Memory CD4 T Cells in Herpes Simplex Viral and HIV Infection
    Thomas R. O’Neil, Kevin Hu, Naomi R. Truong, Sana Arshad, Barbara L. Shacklett, Anthony Lawrence Cunningham, Najla Nasr · 2021 · Viruses
11. Increased homeostatic cytokines and stability of HIV-infected memory CD4 T-cells identify individuals with suboptimal CD4 T-cell recovery on-ART
    María Pino, Susan Pereira Ribeiro, Amélie Pagliuzza, Khader Ghneim, Anum N. Khan, Emily S. Ryan, Justin L. Harper, Colin T. King, Sarah Welbourn, Luca Micci et al. · 2021 · PLoS Pathogens
12. The Alphabet Soup of HIV Reservoir Markers
    Radwa Sharaf, Jonathan Z. Li · 2017 · Current HIV/AIDS Reports
13. Dynamics and mechanisms of clonal expansion of HIV-1-infected cells in a humanized mouse model
    Yorifumi Satou, Hiroo Katsuya, Asami Fukuda et al. · 2017 · Scientific Reports
14. Estimating the contribution of CD4 T cell subset proliferation and differentiation to HIV persistence
    Daniel B. Reeves, Charline Bacchus, Mark D. Fitch, Mohamed Abdel‐Mohsen, Rebecca Hoh, Haelee Ahn, Mars Stone, Frederick M. Hecht, Jeffrey N. Martin, Steven G. Deeks et al. · 2023 · Nature Communications
15. IFIH1 (MDA5) is required for innate immune detection of intron-containing RNA expressed from the HIV-1 provirus
    Mehmet Hakan Guney, Karthika Nagalekshmi, Sean Matthew McCauley, Claudia Carbone, Özkan Aydemir, Jeremy Luban · 2024 · Proceedings of the National Academy of Sciences
16. Clonal Expansion of Human Immunodeficiency Virus–Infected Cells and Human Immunodeficiency Virus Persistence During Antiretroviral Therapy
    James I. Mullins, Lisa M. Frenkel · 2017 · The Journal of Infectious Diseases
17. Peering into the HIV reservoir
    Marcial García, Maria José Buzón, Jose Miguel Benito, Norma Ibón Rallón · 2018 · Reviews in Medical Virology
18. Genetic Diversity, Compartmentalization, and Age of HIV Proviruses Persisting in CD4 ⁺ T Cell Subsets during Long-Term Combination Antiretroviral Therapy
    Jones, Bradley R., Miller, Rachel L., Kinloch, Natalie N., Tsai, Olivia, Rigsby, Hawley, Sudderuddin, Hanwei, Shahid, Aniqa, Ganase, Bruce, Brumme, Chanson J., Harris, Marianne et al. · 2020 · Journal of Virology
19. Antiretroviral Therapy Concentrations Differ in Gut vs. Lymph Node Tissues and Are Associated With HIV Viral Transcription by a Novel RT-ddPCR Assay
    Sulggi A. Lee, Sushama Telwatte, Hiroyu Hatano, Angela D. M. Kashuba, Mackenzie Leigh Cottrell, Rebecca Hoh, Teri J. Liegler, Sophie Stephenson, Ma Somsouk, Peter W. Hunt et al. · 2020 · JAIDS Journal of Acquired Immune Deficiency Syndromes
20. ‘Rinse and Replace’: Boosting T Cell Turnover To Reduce HIV-1 Reservoirs
    Zvi Grossman, Nevil J. Singh, Francesco Roberto Simonetti, Michael M. Lederman, Daniel C. Douek, Steven G. Deeks, Takeshi Kawabe, Gennady Alekseevich Bocharov, Martin Meier‐Schellersheim, Hagit Alon et al. · 2020 · Trends in Immunology
21. HIV-1 Persistence and Chronic Induction of Innate Immune Responses in Macrophages
    Hisashi Akiyama, Suryaram Gummuluru · 2020 · Viruses
22. Experimental Systems for Measuring HIV Latency and Reactivation
    Koh Fujinaga, Daniele C. Cary · 2020 · Viruses
23. Kinetics of Archived M184V Mutation in Treatment-Experienced Virally Suppressed HIV-Infected Patients
    Romain Palich, Elisa Teyssou, Sophie Sayon, Basma Abdi, Cathia Soulié, Lise Cuzin, Roland Tubiana, Marc‐Antoine Valantin, Luminita Schneider, Sophie Seang et al. · 2021 · The Journal of Infectious Diseases
24. The Clonal Expansion Dynamics of the HIV-1 Reservoir: Mechanisms of Integration Site-Dependent Proliferation and HIV-1 Persistence
    Yang-Hui Jimmy Yeh, Kerui Yang, Anya Razmi, Ya‐Chi Ho · 2021 · Viruses
25. Vorinostat Renders the Replication-Competent Latent Reservoir of Human Immunodeficiency Virus (HIV) Vulnerable to Clearance by CD8 T Cells
    Julia Sung, Katherine Sholtis, Jennifer Kirchherr · 2017 · EBioMedicine
26. Predictors of SIV recrudescence following antiretroviral treatment interruption
    Mykola Pinkevych, Christine M. Fennessey, Deborah Cromer, Carolyn Reid, Charles M. Trubey, Jeffrey D. Lifson, Brandon F. Keele, Miles P. Davenport · 2019 · eLife
27. DNA dependent protein kinase (DNA-PK) enhances HIV transcription by promoting RNA polymerase II activity and recruitment of transcription machinery at HIV LTR
    Sonia Zicari, Adhikarimayum Lakhikumar Sharma, Geetaram Sahu, Larisa Dubrovsky, Lin Sun, Han Yue, Tejaswi Jada, Alex Ochem, Gary Leonard Simon, Michael Bukrinsky et al. · 2020 · Oncotarget
28. Intact Human Immunodeficiency Virus (HIV) Reservoir Estimated by the Intact Proviral DNA Assay Correlates With Levels of Total and Integrated DNA in the Blood During Suppressive Antiretroviral Therapy
    Emmanouil Papasavvas, Livio Azzoni, Brian N. Ross, Matthew G. Fair, Zhe Yuan, Kwasi Gyampoh, Agnieszka Mackiewicz, Amanda Sciorillo, Amélie Pagliuzza, Steven M. Lada et al. · 2020 · Clinical Infectious Diseases
29. Measuring the Inducible, Replication-Competent HIV Reservoir Using an Ultra-Sensitive p24 Readout, the Digital ELISA Viral Outgrowth Assay
    Erin L. Stuelke, Katherine Sholtis James, Jennifer Kirchherr · 2020 · Frontiers in Immunology
30. Examination of the APOBEC3 Barrier to Cross Species Transmission of Primate Lentiviruses
    Amit Gaba, Ben Flath, Linda Chelico · 2021 · Viruses
31. Plasma-Derived HIV-1 Virions Contain Considerable Levels of Defective Genomes
    Katie Fisher, Xiao Qian Wang, Ashley Lee, Vincent Morcilla, Anneke de Vries, Eunok Lee, John‐Sebastian Eden, Steven G. Deeks, Anthony Dominic Kelleher, Sarah Palmer · 2022 · Journal of Virology
32. New Assay Reveals Vast Excess of Defective over Intact HIV-1 Transcripts in Antiretroviral Therapy-Suppressed Individuals
    Holly Anne Martin, Gayatri Nikhila Kadiyala, Sushama Telwatte, Adam Wedrychowski, Tsui‐Hua Chen, Sara Morón‐López, Doug Arneson, Rebecca Hoh, Steven G. Deeks, Joseph K. Wong et al. · 2022 · Journal of Virology
33. Antiretroviral therapy reveals triphasic decay of intact SIV genomes and persistence of ancestral variants
    Emily J. Fray, Fengting Wu, Francesco Roberto Simonetti, Carolin Zitzmann, Narmada Sambaturu, Carmen Molina-Parı́s, Alexandra M. Bender, Po-Ting Liu, John D. Ventura, Roger W. Wiseman et al. · 2023 · Cell Host & Microbe
34. Soluble immune checkpoints as correlates for HIV persistence and T cell function in people with HIV on antiretroviral therapy
    Chris Y. H. Chiu, Maya Dyveke Schou, James H. McMahon, Steven G. Deeks, Rémi Fromentin, Nicolas Chomont, Michelle Wykes, Thomas A. Rasmussen, Sharon R. Lewin · 2023 · Frontiers in Immunology
35. Type 1-programmed dendritic cells drive antigen-specific latency reversal and immune elimination of persistent HIV-1
    Jan Kristoff, Mariana L. Palma, Tatiana M. García-Bates, Chengli Shen, Nicolas Sluis‐Cremer, Phalguni Gupta, Charles R. Rinaldo, Robbie B. Mailliard · 2019 · EBioMedicine
36. Differences in inducibility of the latent HIV reservoir in perinatal and adult infection
    Adit Dhummakupt, Jessica H. Rubens, Thuy Anderson, Laura Powell, Bareng A. S. Nonyane, Lilly Siems, Aleisha N. Collinson-Streng, Tricia L. Nilles, Richard Brad Jones, Vicki J. Tepper et al. · 2020 · JCI Insight
37. Engineered deletions of HIV replicate conditionally to reduce disease in nonhuman primates
    Fathima Nuzra Nagoor Pitchai, Elizabeth J. Tanner, Neha Khetan et al. · 2024 · Science
38. Utilizing HIV Proviral DNA to Assess for the Presence of HIV Drug Resistance
    Annemarie M. J. Wensing, Charlotte Charpentier, Vincent Cálvez · 2025 · Clinical Infectious Diseases
39. Paucity of Intact Non-Induced Provirus with Early, Long-Term Antiretroviral Therapy of Perinatal HIV Infection
    Kaitlin Rainwater‐Lovett, Carrie Ziemniak, Douglas C. Watson, Katherine Luzuriaga, George Kelly Siberry, Ann M. Petru, YaHui Chen, Priyanka Uprety, Margaret M. McManus, Ya‐Chi Ho et al. · 2017 · PLoS ONE
40. Barriers to HIV remission research in low‐ and middle‐income countries
    Theresa M. Rossouw, Joseph D. Tucker, Gert Uves van Zyl, Kenly Sikwesi, Catherine C. Godfrey · 2017 · Journal of the International AIDS Society
41. HIV persistence: clonal expansion of cells in the latent reservoir
    Kyungyoon J. Kwon, Robert F. Siliciano · 2017 · Journal of Clinical Investigation
42. Development of sensitive dd PCR assays to reliably quantify the proviral DNA reservoir in all common circulating HIV subtypes and recombinant forms
    Kobus J. Bosman, Annemarie M. J. Wensing, Aster E. Pijning, Willem van Snippenberg, Petra M. van Ham, Dorien C. M. de Jong, Andy I. M. Hoepelman, Monique Nijhuis · 2018 · Journal of the International AIDS Society
43. Blocking Formation of the Stable HIV Reservoir: A New Perspective for HIV-1 Cure
    Nilu P Goonetilleke, Genevieve Clutton, Ron Swanstrom, Sarah Joseph · 2019 · Frontiers in Immunology
44. Nonhuman Primate Models for Studies of AIDS Virus Persistence During Suppressive Combination Antiretroviral Therapy
    Gregory Q. Del Prete, Jeffrey D. Lifson · 2017 · Current topics in microbiology and immunology
45. HIV Protease-Generated Casp8p41, When Bound and Inactivated by Bcl2, Is Degraded by the Proteasome
    Sekar Natesampillai, Nathan W. Cummins, Zilin Nie, Rahul Sampath, Jason V. Baker, Keith Henry, Marilia Rita Pinzone, Una O’Doherty, Eric C. Polley, Gary D. Bren et al. · 2018 · Journal of Virology
46. Levels of Human Immunodeficiency Virus DNA Are Determined Before ART Initiation and Linked to CD8 T-Cell Activation and Memory Expansion
    Genevieve Elizabeth Martin, Matthew J. Pace, Freya M. Shearer, Eva Zilber, Jacob M. Hurst, Jodi Meyerowitz, John Patrick Thornhill, Julianne Lwanga, Helen L. Brown, Nicola Robinson et al. · 2019 · The Journal of Infectious Diseases
47. Elite suppressors have low frequencies of intact HIV-1 proviral DNA
    Abena K. Kwaa, Caroline C. Garliss, Kristen D. Ritter · 2019 · AIDS
48. In Vitro and In Vivo Models of HIV Latency
    James B. Whitney, Richard Brad Jones · 2018 · Advances in experimental medicine and biology
49. Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels compared to protease inhibitor-based therapy
    Alexander O. Pasternak, Jelmer Vroom, Neeltje A. Kootstra, Ferdinand W.N.M. Wit, Marijn de Bruin, Davide De Francesco, Margreet E. Bakker, Caroline Anne Sabin, Alan Winston, Jan M. Prins et al. · 2021 · eLife
50. Clonal Expansion of Infected CD4+ T Cells in People Living with HIV
    John M. Coffin, Stephen H. Hughes · 2021 · Viruses
51. Dendritic Cells Potently Purge Latent HIV-1 Beyond TCR-Stimulation, Activating the PI3K-Akt-mTOR Pathway
    Thijs van Montfort, Renée Marije van der Sluis, Gilles Darcis, Doyle E Beaty, Kevin Groen, Alexander O. Pasternak, Georgios P. Pollakis, Monique A. Vink, Ellen M. Westerhout, Mohamed Hamdi et al. · 2018 · EBioMedicine
52. Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir size
    Daniel I. S. Rosenbloom, Peter Bacchetti, Mars Stone et al. · 2019 · PLoS Computational Biology
53. Improved Detection of HIV Gag p24 Protein Using a Combined Immunoprecipitation and Digital ELISA Method
    Guoxin Wu, Carol A. Cheney, Qian Huang, Daria J. Hazuda, Bonnie J. Howell, Paul D. Zuck · 2021 · Frontiers in Microbiology
54. Intragenic proviral elements support transcription of defective HIV-1 proviruses
    Jeffrey Kuniholm, Elise M.R. Armstrong, Brandy Bernabe, Carolyn Coote, Anna Berenson, Samantha D. Drinan, Alex J. Olson, Xianbao He, Nina Lin, Juan I. Fuxman Bass et al. · 2021 · PLoS Pathogens
55. Immune activation and exhaustion marker expression on T-cell subsets in ART-treated adolescents and young adults with perinatal HIV-1 infection as correlates of viral persistence
    Yuyang Huang, Adit Dhummakupt, Priya Khetan, Tricia L. Nilles, Weiqiang Zhou, Prakriti Mudvari, Joseph Szewczyk, Ya Hui Chen, Eli Boritz, Hongkai Ji et al. · 2023 · Frontiers in Immunology
56. Single-molecule techniques to quantify and genetically characterise persistent HIV
    Xiao Qian Wang, Sarah Palmer · 2018 · Retrovirology
57. Quantification of HIV DNA Using Droplet Digital PCR Techniques
    Elizabeth M. Anderson, Frank M. Maldarelli · 2018 · Current Protocols in Microbiology
58. Increasing contribution of integrated forms to total HIV DNA in blood during HIV disease progression from primary infection
    Pauline Trémeaux, Tiphaine Lenfant, Faroudy Boufassa et al. · 2019 · EBioMedicine
59. Persistent HIV-1 transcription during ART: time to reassess its significance?
    Céline Fombellida-Lopez, Ben Berkhout, Gilles Darcis, Alexander O. Pasternak · 2024 · Current Opinion in HIV and AIDS
60. Differences in HIV Markers between Infected Individuals Treated with Different ART Regimens: Implications for the Persistence of Viral Reservoirs
    Gilles Darcis, Ben Berkhout, Alexander O. Pasternak · 2020 · Viruses
61. Sialyl-LewisX Glycoantigen Is Enriched on Cells with Persistent HIV Transcription during Therapy
    Florent Colomb, Leila B. Giron, Leticia Kuri-Cervantes, Opeyemi S. Adeniji, Tongcui Ma, Harsh Dweep, Emilie Battivelli, Eric M. Verdin, Clovis Steve Palmer, Hiroaki Tateno et al. · 2020 · Cell Reports
62. An Overview of Environmental Resources in Africa: Emerging Issues and Sustainable Exploitation
    Adams Ovie Iyiola, Oluseun Adesola Akinsorotan, Abiola Elizabeth Ojeleye · 2023 · Sustainable development and biodiversity
63. Evaluation of Archival HIV DNA in Brain and Lymphoid Tissues
    Michelli F. Oliveira, Alec P. Pankow, Thomas Vollbrecht, Nikesh M. Kumar, Gemma Cabalero, Caroline C. Ignacio, Mitchell Zhao, Andrej Vitomirov, Ben D. Gouaux, Masato Nakawawa et al. · 2023 · Journal of Virology
64. Review
    Michael J. Bale, Mary F. Kearney · 2019 · Current Opinion in HIV and AIDS
65. The Impact of Cellular Proliferation on the HIV-1 Reservoir
    Maria Virgilio, Kathleen L. Collins · 2020 · Viruses
66. Antibody-mediated depletion of viral reservoirs is limited in SIV-infected macaques treated early with antiretroviral therapy
    Adrienne E. Swanstrom, Taina T. Immonen, Kelli A. Oswald et al. · 2021 · Journal of Clinical Investigation
67. Siglec-9 defines and restrains a natural killer subpopulation highly cytotoxic to HIV-infected cells
    Opeyemi S. Adeniji, Leticia Kuri-Cervantes, Chenfei Yu et al. · 2021 · PLoS Pathogens
68. Trans-Activation Response Element RNA is Detectable in the Plasma of a Subset of Aviremic HIV-1–Infected Patients
    Anžej Hladnik, Jana Ferdin, Katja Goričar, Steven G. Deeks, Boris Matija Peterlin, Ana Plemenitaš, Vita Dolžan, Metka Lenassi · 2017 · Acta chimica slovenica
69. Integrated Assessment of Viral Transcription, Antigen Presentation, and CD8+T Cell Function Reveals Multiple Limitations of Class I-Selective Histone Deacetylase Inhibitors during HIV-1 Latency Reversal
    Talia M. Mota, Chase D. McCann, Ali Danesh, Szu-Han Huang, Dean Magat, Yanqin Ren, Louise Leyre, Tracy D. Bui, Thomas M. Rohwetter, Colin M Kovacs et al. · 2020 · Journal of Virology
70. Integrated Human Immunodeficiency Virus Type 1 Sequence in J-Lat 10.6
    Cheng-Han Chung, Anthony R. Mele, Alexander G. Allen · 2020 · Microbiology Resource Announcements
71. HIV-1 Persistence in Children during Suppressive ART
    Mary Grace Katusiime, Gert Uves van Zyl, Mark Fredric Cotton, Mary F. Kearney · 2021 · Viruses
72. HIV-1 Genomes Are Enriched in Memory CD4 + T-Cells with Short Half-Lives
    Vincent Morcilla, Charline Bacchus, Katie Fisher, Bethany A. Horsburgh, Bonnie M. Hiener, Xiao Qian Wang, Timothy E. Schlub, Mark D. Fitch, Rebecca Hoh, Frederick M. Hecht et al. · 2021 · mBio
73. HIV-1 Infection and Type 1 Interferon: Navigating Through Uncertain Waters
    Sho K. Sugawara, David L. Thomas, Ashwin Balagopal · 2018 · AIDS Research and Human Retroviruses
74. Have Cells Harboring the HIV Reservoir Been Immunoedited?
    Szu-Han Huang, Chase D. McCann, Talia M. Mota, Chao Wang, Steven M. Lipkin, Richard Brad Jones · 2019 · Frontiers in Immunology
75. The Intact Noninducible Latent HIV-1 Reservoir Is Established in an In Vitro Primary T CM Cell Model of Latency
    Indra Sarabia, Szu-Han Huang, Adam R. Ward, Richard Brad Jones, Alberto Bosque · 2021 · Journal of Virology
76. Neuroinflammation associated with proviral DNA persists in the brain of virally suppressed people with HIV
    Sarah J. Byrnes, Janna Jamal Eddine, Jingling Zhou, Emily K. Chalmers, Emma Wanicek, Narin Osman, Trisha A. Jenkins, Michael Roche, Bruce James Brew, Jacob D. Estes et al. · 2025 · Frontiers in Immunology
77. Impact of Antiretroviral Therapy Duration on HIV-1 Infection of T Cells within Anatomic Sites
    Eunok Lee, Susanne von Stockenström, Vincent Morcilla, Lina Odevall, Bonnie M. Hiener, Wei Shao, Wendy Hartogensis, Peter Bacchetti, Jeffrey M. Milush, Teri J. Liegler et al. · 2019 · Journal of Virology
78. Development of an HIV reporter virus that identifies latently infected CD4+ T cells
    Eun Hye Kim, Lara Manganaro, Michael Schotsaert, Brian D. Brown, Lubbertus C. F. Mulder, Viviana R. Simon · 2022 · Cell Reports Methods
79. The Dual-Specificity Kinase DYRK1A Modulates the Levels of Cyclin L2 To Control HIV Replication in Macrophages
    Javan K. Kisaka, Lee Ratner, George B. Kyei · 2019 · Journal of Virology
80. Clinical and evolutionary consequences of HIV adaptation to HLA
    Santiago Ávila‐Ríos, Jonathan M. Carlson, Mina John, Simon Alexander Mallal, Zabrina L. Brumme · 2019 · Current Opinion in HIV and AIDS
81. HIV Proviral Sequence Database: A New Public Database for Near Full-Length HIV Proviral Sequences and Their Meta-Analyses
    Wei Shao, Jigui Shan, Wei-Shau Hu · 2019 · AIDS Research and Human Retroviruses
82. Cellular Activation, Differentiation, and Proliferation Influence the Dynamics of Genetically Intact Proviruses Over Time
    Bethany A. Horsburgh, Bonnie M. Hiener, Katie Fisher, Eunok Lee, Hannah J. Morgan, John‐Sebastian Eden, Susanne von Stockenström, Lina Odevall, Jeffrey M. Milush, Rebecca Hoh et al. · 2021 · The Journal of Infectious Diseases
83. Transient viral replication during analytical treatment interruptions in SIV infected macaques can alter the rebound-competent viral reservoir
    Taina T. Immonen, Christine M. Fennessey, Leslie Lipkey · 2021 · PLoS Pathogens
84. NanoHIV: A Bioinformatics Pipeline for Producing Accurate, Near Full-Length HIV Proviral Genomes Sequenced Using the Oxford Nanopore Technology
    Imogen A. Wright, Kayla Eileen Delaney, Mary Grace Katusiime, Johannes C. Botha, Susan Engelbrecht, Mary F. Kearney, Gert Uves van Zyl · 2021 · Cells
85. Fighting HIV-1 Persistence: At the Crossroads of “Shoc-K and B-Lock”
    Chiara Acchioni, Enrico Palermo, Silvia Sandini, Marta Acchioni, John B. Hiscott, Marco Sgarbanti · 2021 · Pathogens
86. Quantification of Total HIV DNA as a Marker to Measure Viral Reservoir: Methods and Potential Implications for Clinical Practice
    Simone Belmonti, Simona Di Giambenedetto, Francesca Lombardi · 2021 · Diagnostics
87. Non-suppressible viraemia during HIV-1 therapy: a challenge for clinicians
    Andrés Esteban-Cantos, Rocío Montejano, Adriana Pinto-Martínez, Javier Rodríguez-Centeno, Federico Pulido, José Ramón Arribas · 2024 · The Lancet HIV
88. On the Death Rate of Abortively Infected Cells: Estimation from Simian-Human Immunodeficiency Virus Infection
    Ruian Ke, Mian‐er Cong, David Li · 2017 · Journal of Virology
89. Blood biomarkers of expressed and inducible HIV-1
    Anthony Richard Cillo, Francis Hong, Angela Tsai, Alivelu Irrinki, Jasmine Kaur, Derek D. Sloan, Mattie Follen, Romas Geleziunas, Tomáš Cihlář, Sandra S. Win et al. · 2018 · AIDS
90. Associations between HIV-1 DNA copy number, proviral transcriptional activity, and plasma viremia in individuals off or on suppressive antiretroviral therapy
    Feiyu F. Hong, Jana L. Jacobs, Evgenia Aga, Anthony Richard Cillo, Elizabeth Fyne, Dianna L. Koontz, Lu Zheng, John W. Mellors · 2018 · Virology
91. Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing
    Bonnie M. Hiener, John‐Sebastian Eden, Bethany A. Horsburgh · 2018 · Journal of Visualized Experiments
92. The Splice of Life: Does RNA Processing Have a Role in HIV-1 Persistence?
    Alexander O. Pasternak, Ben Berkhout · 2021 · Viruses
93. Chronic HIV Transcription, Translation, and Persistent Inflammation
    Jonathan M. Kilroy, Andrew A. Leal, Andrew J. Henderson · 2024 · Viruses
94. Emerging PCR-Based Techniques to Study HIV-1 Reservoir Persistence
    Laurens Lambrechts, Basiel Cole, Sofie Rutsaert · 2020 · Viruses
95. Nicotinamide activates latent HIV-1 ex vivo in ART suppressed individuals, revealing higher potency than the association of two methyltransferase inhibitors, chaetocin and BIX01294
    Sadia Samer, Muhammad Shoaib Arif, Leila B. Giron, Jean Paulo Lopes Zukurov, James Hunter, Bruna Tereso Santillo, Gislene Mitsue Namiyama, Juliana Galinskas, Shirley Vasconcelos Komninakis, Telma Miyuki Oshiro et al. · 2020 · The Brazilian Journal of Infectious Diseases
96. HIV latency reversal agents: A potential path for functional cure?
    Juliana Romano Lopes, Diego Eidy Chiba, Jean Leandro dos Santos · 2021 · European Journal of Medicinal Chemistry
97. Subtype C HIV-1 reservoirs throughout the body in ART-suppressed individuals
    Zhou Liu, Peter Julius, Guobin Kang, John T. West, Charles A. Wood · 2022 · JCI Insight
98. Role of co-expressed APOBEC3F and APOBEC3G in inducing HIV-1 drug resistance
    Nazanin Mohammadzadeh, Robin P. Love, Richard M. Gibson, Eric J. Arts, Art F. Y. Poon, Linda Chelico · 2019 · Heliyon
99. Improving HIV Outgrowth by Optimizing Cell-Culture Conditions and Supplementing With all-trans Retinoic Acid
    Yuwei Zhang, Delphine Planas, Laurence Raymond Marchand, Marta Massanella, Huicheng Chen, Vanessa Sue Wacleche, Annie Gosselin, Jean-Philippe Goulet, Mario Filion, Jean‐Pierre Routy et al. · 2020 · Frontiers in Microbiology
100. Clinical validation of a quantitative HIV-1 DNA droplet digital PCR assay: Applications for detecting occult HIV-1 infection and monitoring cell-associated HIV-1 dynamics across different subtypes in HIV-1 prevention and cure trials
     Laura Powell, Adit Dhummakupt, Lilly Siems et al. · 2021 · Journal of Clinical Virology